These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 21316661

  • 1. Serum complement C3 has a stronger association with insulin resistance than high-sensitivity C-reactive protein in women with polycystic ovary syndrome.
    Yang S, Li Q, Song Y, Tian B, Cheng Q, Qing H, Zhong L, Xia W.
    Fertil Steril; 2011 Apr; 95(5):1749-53. PubMed ID: 21316661
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF.
    Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
    [Abstract] [Full Text] [Related]

  • 4. Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome.
    Cakal E, Ustun Y, Engin-Ustun Y, Ozkaya M, Kilinç M.
    Gynecol Endocrinol; 2011 Jul; 27(7):491-5. PubMed ID: 20626239
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.
    Tosi F, Dorizzi R, Castello R, Maffeis C, Spiazzi G, Zoppini G, Muggeo M, Moghetti P.
    Eur J Endocrinol; 2009 Nov; 161(5):737-45. PubMed ID: 19713424
    [Abstract] [Full Text] [Related]

  • 7. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [Abstract] [Full Text] [Related]

  • 8. Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome.
    El-Mesallamy HO, Abd El-Razek RS, El-Refaie TA.
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):178-82. PubMed ID: 23434327
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The insulin-resistant phenotype of polycystic ovary syndrome.
    Svendsen PF, Madsbad S, Nilas L.
    Fertil Steril; 2010 Aug; 94(3):1052-8. PubMed ID: 19580964
    [Abstract] [Full Text] [Related]

  • 11. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B, Mitkov M.
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [Abstract] [Full Text] [Related]

  • 12. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, Baş O.
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [Abstract] [Full Text] [Related]

  • 13. Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.
    Glintborg D, Højlund K, Andersen M, Henriksen JE, Beck-Nielsen H, Handberg A.
    Diabetes Care; 2008 Feb; 31(2):328-34. PubMed ID: 18000176
    [Abstract] [Full Text] [Related]

  • 14. Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?
    Engin-Ustün Y, Ustün Y, Meydanli MM, Kafkasli A, Yetkin G.
    Gynecol Endocrinol; 2006 Jun; 22(6):324-8. PubMed ID: 16785157
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS, Rouzi AA.
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [Abstract] [Full Text] [Related]

  • 18. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA, Shin SY, Yoon BK, Choi D.
    Gynecol Endocrinol; 2007 Jun; 23(8):461-7. PubMed ID: 17852414
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. C-reactive protein and homocysteine levels are associated with abnormal heart rate recovery in women with polycystic ovary syndrome.
    Kaya C, Akgül E, Pabuccu R.
    Fertil Steril; 2010 Jun; 94(1):230-5. PubMed ID: 19362308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.